Inhaled and systemic heparin as a repurposed direct antiviral drug for prevention and treatment of COVID-19
Carina Conzelmann, Janis A Müller, Lukas Perkhofer, Konstantin MJ Sparrer, Alexander N Zelikin, Jan Münch and Alexander Kleger
DOI: https://doi.org/10.7861/clinmed.2020-0351
Clin Med November 2020 Carina Conzelmann
AInstitute of Molecular Virology, Ulm University Medical Centre, Ulm, Germany
*equal contributions
Roles: PhD student
Janis A Müller
BInstitute of Molecular Virology, Ulm University Medical Centre, Ulm, Germany
*equal contributions
Roles: postdoctoral fellow
Lukas Perkhofer
CDepartment of Internal Medicine, Ulm University Hospital, Ulm, Germany
Roles: attending physician in gastroenterology
Konstantin MJ Sparrer
DInstitute of Molecular Virology, Ulm University Medical Centre, Ulm, Germany
Roles: junior principal investigator
Alexander N Zelikin
EDepartment of Chemistry and iNano Interdisciplinary Nanoscience Centre, Aarhus University, Aarhus, Denmark
#equal contribution and joint supervision
Roles: associate professor
Jan Münch
FInstitute of Molecular Virology, Ulm University Medical Centre, Ulm, Germany
Roles: professor of molecular virology
Alexander Kleger
GDepartment of Internal Medicine, Ulm University Hospital, Ulm, Germany
#equal contribution and joint supervision
Roles: professor of molecular oncology
Article Information
vol. 20 no. 6 e218-e221
PubMed:
Published By:
Print ISSN:
Online ISSN:
History:
- Published online November 16, 2020.
Article Versions
- Latest version (August 30, 2020 - 05:32).
- You are viewing the most recent version of this article.
Copyright & Usage:
© 2020 Royal College of Physicians 2020. All rights reserved.
Author Information
- Carina Conzelmann, PhD studentA,*,
- Janis A Müller, postdoctoral fellowB,*,
- Lukas Perkhofer, attending physician in gastroenterologyC,
- Konstantin MJ Sparrer, junior principal investigatorD,
- Alexander N Zelikin, associate professorE,#,
- Jan Münch, professor of molecular virologyF and
- Alexander Kleger, professor of molecular oncologyG,#⇑
- AInstitute of Molecular Virology, Ulm University Medical Centre, Ulm, Germany
- BInstitute of Molecular Virology, Ulm University Medical Centre, Ulm, Germany
- CDepartment of Internal Medicine, Ulm University Hospital, Ulm, Germany
- DInstitute of Molecular Virology, Ulm University Medical Centre, Ulm, Germany
- EDepartment of Chemistry and iNano Interdisciplinary Nanoscience Centre, Aarhus University, Aarhus, Denmark
- FInstitute of Molecular Virology, Ulm University Medical Centre, Ulm, Germany
- GDepartment of Internal Medicine, Ulm University Hospital, Ulm, Germany
- *equal contributions
- #equal contribution and joint supervision
- Address for correspondence: Prof Alexander Kleger, Department of Internal Medicine 1, Ulm University Medical Center, Ulm, Germany. Email: alexander.kleger{at}uni-ulm.de
Article usage
Article Tools
Inhaled and systemic heparin as a repurposed direct antiviral drug for prevention and treatment of COVID-19
Carina Conzelmann, Janis A Müller, Lukas Perkhofer, Konstantin MJ Sparrer, Alexander N Zelikin, Jan Münch, Alexander Kleger
Clinical Medicine Nov 2020, 20 (6) e218-e221; DOI: 10.7861/clinmed.2020-0351
Citation Manager Formats
Inhaled and systemic heparin as a repurposed direct antiviral drug for prevention and treatment of COVID-19
Carina Conzelmann, Janis A Müller, Lukas Perkhofer, Konstantin MJ Sparrer, Alexander N Zelikin, Jan Münch, Alexander Kleger
Clinical Medicine Nov 2020, 20 (6) e218-e221; DOI: 10.7861/clinmed.2020-0351
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.